Bioprocess Chromatography: Principles, Applications and Advances in Biomolecule Purification

Alexander Armstrong^*
*Correspondence: Alexander Armstrong, Department of Biochemical Engineering, University of London, London, UK, Email:

Keywords

Bioprocess chromatography • Stationary phase • Real-time monitoring

Introduction

Bioprocess chromatography is grounded in the principles of traditional chromatography, where a mixture is separated into its individual components based on their specific interactions with a stationary phase and a mobile phase. However, the unique nature of biological molecules introduces distinct challenges and considerations in bioprocess chromatography. The stationary phase in bioprocess chromatography is typically a matrix or resin that facilitates the separation of biomolecules. Common stationary phases include ion exchange resins, affinity chromatography resins, hydrophobic interaction resins and size exclusion resins. Each type of resin exploits specific interactions with the biomolecules to achieve separation [1].

Literature Review

This technique separates molecules based on their net charge. The stationary phase contains charged groups that attract and bind oppositely charged biomolecules, allowing for differentiation between proteins and other charged molecules. This method involves the use of ligands on the stationary phase that specifically interact with the target biomolecule. This high specificity allows for highly selective separation, making affinity chromatography a powerful tool for purifying biopharmaceuticals. HIC exploits differences in hydrophobicity among biomolecules. The stationary phase is designed to have hydrophobic regions and as a sample passes through, molecules with varying hydrophobic interactions are separated.

Discussion

SEC separates molecules based on their size. Larger molecules are excluded from the porous structure of the stationary phase, allowing smaller molecules to pass through and be collected. The mobile phase, or eluent, is a fluid that carries the sample through the stationary phase. The choice of mobile phase depends on the specific chromatographic technique being employed. Common mobile phases include buffers, salt solutions and organic solvents. Bioprocess chromatography finds widespread applications in various industries, primarily due to its ability to purify and isolate biomolecules with high specificity. In the pharmaceutical industry, bioprocess chromatography is integral to the production of biopharmaceuticals such as monoclonal antibodies, vaccines and therapeutic proteins. The stringent purity requirements for these products necessitate advanced chromatographic techniques to ensure the removal of impurities and contaminants [2].

Bioprocess chromatography is employed in the food and beverage industry for the purification of enzymes, flavours and other bioactive compounds. This ensures that the final products meet quality standards and regulatory requirements. In the field of biofuel production, bioprocess chromatography plays a role in purifying enzymes involved in the conversion of biomass into biofuels. High-purity enzymes are essential for optimal performance in biofuel production processes. Bioprocess chromatography is a cornerstone in bio analytical research, enabling scientists to isolate and study specific biomolecules. This is crucial for understanding biological processes, developing new drugs and advancing various fields of biotechnology [3].

The field of bioprocess chromatography has witnessed significant advancements in recent years, driven by the demand for improved efficiency, higher throughput and reduced costs. Traditionally, chromatography has been performed in a batch mode, where a finite amount of sample is processed in each cycle. Continuous chromatography, on the other hand, allows for a continuous flow of sample through the column, leading to higher productivity and reduced processing time. This is particularly advantageous in large-scale industrial applications. Automation and robotics have been integrated into bioprocess chromatography systems, enabling high-throughput screening of various conditions and parameters. This accelerates the optimization of chromatographic processes and significantly reduces the time required for method development [4].

Multi-modal chromatography utilizes resins that incorporate multiple separation mechanisms. This approach allows for a more versatile and efficient separation of complex mixtures, reducing the need for multiple chromatographic steps and simplifying the purification process. The development of novel stationary phase materials with enhanced selectivity and stability has contributed to improved chromatographic performance. This includes the use of mixed-mode resins that combine ion exchange, hydrophobic interaction and affinity interactions in a single step. Real-time monitoring and control of chromatographic processes have become more sophisticated with the integration of advanced analytics and sensors. This ensures consistent product quality and allows for timely adjustments to optimize the purification process. While bioprocess chromatography has advanced significantly, several challenges persist. The complexity of biological mixtures, the need for high purity in biopharmaceuticals and the scale-up of chromatographic processes for industrial production pose on-going challenges. The transition from laboratory-scale to industrial-scale chromatography presents challenges in terms of column size, packing efficiency and process economics. Developing effective scale-up strategies is crucial for the widespread adoption of bioprocess chromatography in large-scale production [5].

Continuous chromatography offers advantages in terms of productivity and efficiency, but optimizing continuous processes, including resin regeneration and buffer management, is an ongoing area of research. Balancing the benefits of continuous processing with the practical challenges is essential for successful implementation. Ensuring the robustness and reliability of bioprocess chromatography under varying conditions is essential for consistent and reproducible results. This involves understanding the impact of different feedstock compositions, impurity profiles and process parameters on the chromatographic process. Integrating bioprocess chromatography seamlessly with downstream processing steps is critical for a streamlined and efficient bio manufacturing workflow. Developing integrated processes that minimize the number of purification steps and reduce overall processing time is a key focus for future research [6].

Conclusion

Bioprocess chromatography stands at the forefront of modern biotechnology, serving as a cornerstone for the purification of complex biomolecules in various industries. The principles of this technique, rooted in the fundamentals of chromatography, have been adapted and refined to meet the specific challenges posed by biological molecules. Continued exploration of novel chromatographic techniques, such as expanded bed chromatography and simulated moving bed chromatography, holds the potential to further improve the efficiency and cost-effectiveness of bioprocess chromatography.

Acknowledgement

None.

Conflict of Interest

There is no conflict of interest by author.

References

1. Husain, S. R., J. Han, P. Au and K. Shannon, et al. "Gene therapy for cancer: Regulatory considerations for approval."
   Cancer Gene Ther 22 (2015): 554-563.

   Google Scholar, Crossref, Indexed at

2. Moleirinho, Mafalda G., Sara Rosa, Manuel JT Carrondo and Ricardo JS Silva, et al. "Clinical-grade oncolytic adenovirus purification using polysorbate 20 as an alternative for cell lysis." Curr Gene Ther 18, (2018): 366-374.

   Google Scholar, Crossref, Indexed at

3. James, Kevin T., Brad Cooney, Kate Agopsowicz and Mary Ann Trevors, et al "Novel high-throughput approach for purification of infectious virions." Sci Rep 6 (2016): 36826.

   Google Scholar, Crossref, Indexed at

4. Wang, Qiang, Meng Chen, Guoqiang Shan and Pengyu Chen, et al. "Bioaccumulation and biomagnification of emerging bisphenol analogues in aquatic organisms from Taihu Lake, China."Sci Total Environ 598 (2017): 814-820.

   Google Scholar, Crossref, Indexed at

5. Adeyi, Adebola A. and Babafemi A. Babalola. "Bisphenol-A (BPA) in foods commonly consumed in Southwest Nigeria and its human health risk."Sci Rep (2019): 17458.

   Google Scholar, Crossref, Indexed at

6. Clément, Nathalie and Joshua C. Grieger. "Manufacturing of recombinant adeno-associated viral vectors for clinical trials." Mol Ther Methods Clin Dev 3 (2016):89-95.

   Google Scholar, Crossref, Indexed at